Sisram Medical Ltd (1696.HK)
| Previous close | 3.220 |
| Open | 3.260 |
| Bid | 3.120 x 0 |
| Ask | 3.160 x 0 |
| Day's range | 2.960 - 3.260 |
| 52-week range | 2.960 - 12.860 |
| Volume | |
| Avg. volume | 623,259 |
| Market cap | 1.458B |
| Beta (5Y monthly) | 1.45 |
| PE ratio (TTM) | 5.89 |
| EPS (TTM) | 0.530 |
| Earnings date | 21 Mar 2024 |
| Forward dividend & yield | 0.17 (5.37%) |
| Ex-dividend date | 24 Aug 2023 |
| 1y target est | 8.07 |
PR NewswireSisram Medical Announces 2023 Annual Results
Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a global consumer wellness group, featuring a distinguished synergistic ecosystem of business building blocks and consumer-focused branding, including energy-based devices, injectables, aesthetics and digital dentistry, personal care, and more, today announced its audited consolidated annual results for the year ended December 31, 2023 (the "Reporting Period").
PR Newswire/C O R R E C T I O N -- Sisram Medical Ltd/
Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a global consumer wellness group, featuring a distinguished synergistic ecosystem of business building blocks and consumer-focused branding, including Energy Based Devices, Injectables, Aesthetic and Digital Dentistry, Personal Care, and more, today announced that it expects to release its annual results for FY2023, ended December 31, on Wednesday, March 20, 2024.
PR NewswireSisram Medical Announces First-Half 2023 Financial Results
Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a global consumer wellness group, featuring a distinguished synergistic ecosystem of business building blocks and consumer-focused branding, including energy-based devices, injectables, aesthetics and digital dentistry, personal care, and more, today announced its unaudited consolidated interim results for the six months ended June 30, 2023 (the "Reporting Period").
